Abstract
The advent of lecanemab is a hope not only for people with dementia and their families but also for society as a whole. However, the effectiveness of lecanemab is limited, and the need to inform patients of their dementia may emphasize negative aspects more than ever as "early diagnosis leads to early despair." In this situation, it is important to provide post-diagnostic support to make the "time spent living with dementia," which is prolonged by lecanemab, as meaningful as possible. In this review, the authors introduce the "Peer Support Activities for people with mild dementia and their families," a post-diagnosis support program for those diagnosed early in the course of the disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
